Healthcare

NanoViricides' NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu

NanoViricides' NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu

NanoViricides, Inc. highlights NV-387, its broad-spectrum antiviral candidate, as a potential game-changer in combating emerging COVID-19 variants and Bird Flu strains, showcasing its superior performance in animal models and readiness for cGMP manufacturing.

June 18, 2025
Cure Alzheimer’s Fund Honors Breakthrough Research with Jeffrey L. Morby Prize

Cure Alzheimer’s Fund Honors Breakthrough Research with Jeffrey L. Morby Prize

The Cure Alzheimer’s Fund has awarded the Jeffrey L. Morby Prize to researchers Andrew S. Yoo and Zhao Sun for their innovative study on modeling late-onset Alzheimer’s disease, marking a significant step forward in understanding and potentially treating the condition.

June 18, 2025
Study Links Microplastic Pollution in Coastal Waters to Increased Risk of Cardiometabolic Diseases

Study Links Microplastic Pollution in Coastal Waters to Increased Risk of Cardiometabolic Diseases

Residents of U.S. coastal counties with high levels of microplastic pollution in nearby waters face significantly higher rates of Type 2 diabetes, coronary artery disease, and stroke, highlighting the potential public health crisis posed by plastic pollution.

June 18, 2025
Innovative Behavioral Health Research Project Launches in Ohio

Innovative Behavioral Health Research Project Launches in Ohio

A collaborative research project between Northwoods, Concord Counseling, and The Ohio State University aims to explore the benefits of Case Aide Services in behavioral health, potentially reducing staff burnout and improving service delivery.

June 18, 2025
Podcast 'MidLife Crisis: Bomb Drop and Beyond' Sparks Conversation on Untreated Midlife Crisis

Podcast 'MidLife Crisis: Bomb Drop and Beyond' Sparks Conversation on Untreated Midlife Crisis

The podcast 'MidLife Crisis: Bomb Drop and Beyond' has rapidly gained traction, highlighting the often overlooked emotional turmoil of midlife crisis and its widespread impact on families and society, advocating for its recognition in the mental health field.

June 18, 2025
Florida Seminars Shed Light on Baker Act's Human Rights Implications

Florida Seminars Shed Light on Baker Act's Human Rights Implications

The Citizens Commission on Human Rights of Florida is hosting seminars to educate the public on the Baker Act's impact on human rights, highlighting concerns over coercive psychiatry and its effects on individuals, especially children.

June 18, 2025
Holly Kleiman Advocates for Holistic Wellness and Announces National Expansion of Sapphire + Salt

Holly Kleiman Advocates for Holistic Wellness and Announces National Expansion of Sapphire + Salt

Holly Kleiman, a notable figure in holistic health care, shares her vision for a wellness revolution on Innovator's Journey, highlighting the expansion of her spa, Sapphire + Salt, which focuses on detoxification and cellular balance.

June 18, 2025
The Christmas Palace Celebrates Christmas in July with Community and Charity in Focus

The Christmas Palace Celebrates Christmas in July with Community and Charity in Focus

The Christmas Palace is hosting a unique Christmas in July event in South Florida, blending holiday cheer with summer fun, while supporting Joe DiMaggio Children’s Hospital through toy donations.

June 18, 2025
Study Reveals Unchanged Prevalence of Psoriasis in the U.S., Highlights Need for Better Treatments

Study Reveals Unchanged Prevalence of Psoriasis in the U.S., Highlights Need for Better Treatments

A recent study published in the Journal of American Academy of Dermatology shows the prevalence of psoriasis among U.S. adults remains steady at 3% over the last decade, underscoring the ongoing need for effective treatments and improved diagnostic access.

June 17, 2025
Soligenix Advances Treatment for Behçet’s Disease with New Clinical Trial

Soligenix Advances Treatment for Behçet’s Disease with New Clinical Trial

Soligenix Inc. has initiated a clinical trial for SGX945, a potential treatment for Behçet’s disease, a rare autoimmune disorder with limited treatment options, highlighting a significant step towards addressing the unmet needs of patients globally.

June 17, 2025
Quantum BioPharma Advances MS Research with Groundbreaking PET Imaging Study

Quantum BioPharma Advances MS Research with Groundbreaking PET Imaging Study

Quantum BioPharma Ltd. has initiated a pioneering PET imaging study with Massachusetts General Hospital to track myelin integrity in multiple sclerosis patients, potentially revolutionizing treatment evaluation.

June 17, 2025
HeartBeam Inc. and AccurKardia Collaborate to Enhance Remote Cardiac Monitoring

HeartBeam Inc. and AccurKardia Collaborate to Enhance Remote Cardiac Monitoring

HeartBeam Inc. partners with AccurKardia to integrate FDA-cleared ECG analysis software into its portable cardiac monitoring device, aiming to improve arrhythmia detection and patient care accessibility.

June 17, 2025
GeoVax's GEO-CM04S1 Shows Superior Immune Response in CLL Patients Compared to mRNA Vaccines

GeoVax's GEO-CM04S1 Shows Superior Immune Response in CLL Patients Compared to mRNA Vaccines

GeoVax Labs, Inc. reports that its GEO-CM04S1 vaccine has demonstrated superior T cell responses in chronic lymphocytic leukemia (CLL) patients compared to an authorized mRNA COVID-19 vaccine, highlighting potential advancements in protecting immunocompromised individuals.

June 17, 2025
Stonegate Capital Partners Initiates Coverage on Cingulate Inc. with Focus on ADHD Treatment Innovation

Stonegate Capital Partners Initiates Coverage on Cingulate Inc. with Focus on ADHD Treatment Innovation

Stonegate Capital Partners has begun coverage on Cingulate Inc., highlighting the company's progress with CTx-1301, a potential breakthrough in ADHD treatment, targeting a significant market opportunity.

June 17, 2025
Carolindica Introduces Hemp-Derived Nano THC Pops for a Summer Wellness Experience

Carolindica Introduces Hemp-Derived Nano THC Pops for a Summer Wellness Experience

Carolindica's launch of Nano THC Pops offers adults a novel, fun way to enjoy hemp-derived Delta-9 THC through freezeable, drinkable, or mixable ice pops in six fruity flavors, combining nostalgia with the benefits of nano-emulsified THC for rapid absorption.

June 17, 2025
Updated Guide to Luxury Couples Rehabs Accepting Insurance Now Available

Updated Guide to Luxury Couples Rehabs Accepting Insurance Now Available

CouplesRehabGuide.com has updated its resources to include luxury rehabilitation centers for couples that accept major insurance providers, addressing the need for high-quality, private treatment options that are financially accessible.

June 17, 2025
CollectionPro Revolutionizes Out-of-Network Recovery with Legal Expertise and No-Risk Model

CollectionPro Revolutionizes Out-of-Network Recovery with Legal Expertise and No-Risk Model

CollectionPro Services LLC is transforming the out-of-network collections space by offering healthcare providers a legal-first approach with a no-risk financial model, ensuring fair reimbursements in a challenging healthcare payment landscape.

June 17, 2025
Brisa Therapeutics Highlights Nature's Impact on Mental Wellness in Podcast Feature

Brisa Therapeutics Highlights Nature's Impact on Mental Wellness in Podcast Feature

Brisa Therapeutics discusses the therapeutic benefits of nature on mental and emotional health in a recent podcast episode, emphasizing the science behind how natural environments facilitate healing and nervous system regulation.

June 17, 2025
Fractured to Freedom: A New Guide to Personal Healing Launches This Independence Day

Fractured to Freedom: A New Guide to Personal Healing Launches This Independence Day

A new book, 'Fractured to Freedom,' set to release on July 4, offers a unique perspective on personal liberation and healing, blending ancient wisdom with practical tools for self-improvement.

June 17, 2025
BiomX Inc. Achieves Breakthrough in Treating Antibiotic-Resistant Infections

BiomX Inc. Achieves Breakthrough in Treating Antibiotic-Resistant Infections

BiomX Inc. has reported successful Phase 2 clinical trial results for treating diabetic foot bone infections and cystic fibrosis with bacteriophage therapy, offering a potential solution to the growing antibiotic resistance crisis.

June 16, 2025
HeartBeam Inc. Pioneers Cable-Free ECG System for At-Home Cardiac Monitoring

HeartBeam Inc. Pioneers Cable-Free ECG System for At-Home Cardiac Monitoring

HeartBeam Inc. introduces a revolutionary cable-free system for synthesizing 12-lead ECGs from 3D signals, enabling patients to record their symptoms anywhere, potentially transforming cardiac care by facilitating early detection and timely intervention.

June 16, 2025
Jupiter Neurosciences' Dual Strategy Paves Way for Biotech Innovation and Revenue Stability

Jupiter Neurosciences' Dual Strategy Paves Way for Biotech Innovation and Revenue Stability

Jupiter Neurosciences Inc. combines clinical drug development with a direct-to-consumer product line to address neuroinflammation and rare diseases, ensuring both long-term impact and short-term revenue amidst industry challenges.

June 16, 2025
Lantern Pharma Inc. Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial

Lantern Pharma Inc. Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial

Lantern Pharma Inc. (NASDAQ: LTRN) has reported a significant clinical outcome in its Phase 2 HARMONIC(TM) trial, showcasing the potential of its LP-300 treatment in combination with standard chemotherapy for never-smoker patients with advanced non-small cell lung cancer (NSCLC), marking a pivotal moment in oncology treatment.

June 16, 2025
Tonix Pharmaceuticals Reports Promising Phase 3 Results for Fibromyalgia Treatment

Tonix Pharmaceuticals Reports Promising Phase 3 Results for Fibromyalgia Treatment

Tonix Pharmaceuticals Holding Corp. has unveiled positive Phase 3 trial data for TNX-102 SL, a potential breakthrough in fibromyalgia treatment, showcasing significant pain reduction and improved sleep quality, marking a significant advancement in pain management therapies.

June 16, 2025
CRVA Launches 50th Anniversary Road Trip to Support Care Camps for Children with Cancer

CRVA Launches 50th Anniversary Road Trip to Support Care Camps for Children with Cancer

The Canadian Recreational Vehicle Association embarks on a cross-country tour to celebrate its 50th anniversary, promote the RV lifestyle, and raise funds for Care Camps Foundation, supporting children with cancer.

June 16, 2025
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam Inc.'s innovative credit card-sized ECG device has shown a 93.4% diagnostic agreement with standard ECGs in the VALID-ECG study, marking a significant step towards portable cardiac care solutions.

June 16, 2025
Healthcare Triangle Expands Digital Healthcare Portfolio with Strategic Acquisitions

Healthcare Triangle Expands Digital Healthcare Portfolio with Strategic Acquisitions

Healthcare Triangle, Inc. has finalized the acquisition of Niyama Healthcare and Ezovion Solutions, marking a significant step in enhancing its digital healthcare offerings and global market presence.

June 16, 2025
GeoVax Gains EMA Support for Streamlined Mpox and Smallpox Vaccine Development

GeoVax Gains EMA Support for Streamlined Mpox and Smallpox Vaccine Development

GeoVax Labs, Inc. receives favorable regulatory guidance from the European Medicines Agency, simplifying the development pathway for its GEO-MVA vaccine against Mpox and smallpox, marking a significant step towards addressing global vaccine shortages.

June 16, 2025
Dr. Antonio Ganios Introduces Comprehensive Family Dental Care in Morton Grove

Dr. Antonio Ganios Introduces Comprehensive Family Dental Care in Morton Grove

Dr. Antonio Ganios is now offering personalized dental care for all ages at ProCare Family Dental in Morton Grove, IL, emphasizing preventive care and modern treatments to meet the unique needs of each family member.

June 15, 2025
Creative Biolabs Enhances Non-IgG Antibody Development with Innovative Platform

Creative Biolabs Enhances Non-IgG Antibody Development with Innovative Platform

Creative Biolabs introduces a groundbreaking platform for the development of non-IgG antibodies, addressing key challenges in yield, purification, and stability to unlock their therapeutic potential.

June 14, 2025
PreviousPage 73 of 92Next